Longeveron (LGVN) Stock: Buy, Sell, or Hold?
LGVN - Longeveron Inc. Common Stock
$2.58
-0.01 (-0.39%)
▼
5d:
-8.19%
30d:
-61.95%
90d:
+297.23%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 03, 2026
30d
Get Alerted When LGVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LGVN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: LGVN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: LGVN is currently trading at $2.58, which is considered slightly low relative to its 30-day fair value range of $2.32 to $6.84.
Technical Outlook: Technically, LGVN is in a strong uptrend. Immediate support is located at $2.32, while resistance sits at $2.97.
Market Sentiment: LGVN scores 79/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $61.25 (+2274.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LGVN is in a strong uptrend. Immediate support is located at $2.32, while resistance sits at $2.97.
Market Sentiment: LGVN scores 79/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $61.25 (+2274.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.32 -
$6.84
Company Quality Score
67/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (79/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 2274.0% below Wall St target ($61.25)
- CAUTION: Bottoming setup, but lagging the sector by 75% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-8.2%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$2.32 -
$6.84
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.32
Resistance Level
$2.97
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.52
Wall Street Target
$61.25
(+2274.0%)
Revenue Growth (YoY)
-9.2%
Share & Embed Analysis
Last updated: October 03, 2026 1:39 PM ET
Data refreshes hourly during market hours. Next update: 2:39 PM
Data refreshes hourly during market hours. Next update: 2:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LGVN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$92 | 46 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 65 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$109 | 76 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 42 HOLD |
